Ítem
Solo Metadatos

Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia

Mostrar el registro sencillo de la publicación
dc.creatorWU, LIHTEHspa
dc.creatorEVANS, TEODOROspa
dc.creatorARÉVALO, J FERNANDOspa
dc.creatorBERROCAL, MARÍA H.spa
dc.creatorRODRÍGUEZ, FRANCISCO J.spa
dc.creatorHSU, MARÍAspa
dc.creatorSÁNCHEZ, JUAN G.spa
dc.date.accessioned2020-05-25T23:58:49Z
dc.date.available2020-05-25T23:58:49Z
dc.date.created2008spa
dc.description.abstractPURPOSE: To report the visual outcomes and ocular complications of intravitreal triamcinolone acetonide (IVTA) in the treatment of the nonproliferative stage of type II idiopathic parafoveal telangiectasia (IPT). METHODS: Retrospective, multicenter, uncontrolled interventional case series of 19 eyes of 14 consecutive patients with the nonproliferative stage of IPT that had undergone at least one intravitreal injection of 4 mg of triamcinolone acetonide. Demographic, medical, and ocular data were obtained through chart review. The main outcome measures included best-corrected visual acuity at several timepoints of follow up and ocular complications. RESULTS: At baseline the mean logMAR visual acuity was 0.83 ± 0.41 (Snellen 20/135, range 0.3-2). After an average follow-up of 21.2 months (range 6-44 months), the mean logMAR visual acuity remained essentially unchanged from baseline. At 3 months, the logMAR visual acuity was 0.86 ± 0.44 (Snellen 20/145, P = 0.8378), at 6 months 0.86 ± 0.42 (Snellen 20/145, P = 0.8149), at 12 months 0.87 ± 0.46 (Snellen 20/148, P > 0.9999), at 18 months 0.84 ± 0.35 (Snellen 20/138, P = 0.8385), and at the last follow-up 0.82 ± 0.44 (Snellen 20/132, P = 0.9301). Seven eyes were reinjected once. Ten of 19 eyes (53%) developed cataract (3 eyes underwent phacoemulsification and intraocular lens implantation) and 7 of 19 eyes (37%) had an elevated intraocular pressure, none of which required surgical treatment. CONCLUSION: IVTA does not seem to improve visual acuity in most eyes with the nonproliferative stage of IPT. © The Ophthalmic Communications Society, Inc.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1097/IAE.0b013e31814cf03e
dc.identifier.issn15392864
dc.identifier.issn0275004X
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/22935
dc.language.isoengspa
dc.relation.citationEndPage319
dc.relation.citationIssueNo. 2
dc.relation.citationStartPage314
dc.relation.citationTitleRetina
dc.relation.citationVolumeVol. 28
dc.relation.ispartofRetina, ISSN:15392864, 0275004X, Vol.28, No.2 (2008); pp. 314-319spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-42449151372&doi=10.1097%2fIAE.0b013e31814cf03e&partnerID=40&md5=3e44e336ff064325ce57e87f8bda6ed3spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordTriamcinolonespa
dc.subject.keywordGlucocorticoidspa
dc.subject.keywordTriamcinolone acetonidespa
dc.subject.keywordAdultspa
dc.subject.keywordAgedspa
dc.subject.keywordArticlespa
dc.subject.keywordCataractspa
dc.subject.keywordCataract extractionspa
dc.subject.keywordClinical articlespa
dc.subject.keywordControlled studyspa
dc.subject.keywordDisease severityspa
dc.subject.keywordDrug effectspa
dc.subject.keywordFemalespa
dc.subject.keywordFollow upspa
dc.subject.keywordHumanspa
dc.subject.keywordIntraocular pressurespa
dc.subject.keywordLens implantspa
dc.subject.keywordMalespa
dc.subject.keywordPhacoemulsificationspa
dc.subject.keywordTelangiectasiaspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordType 2 idiopathic parafoveal telangiectasiaspa
dc.subject.keywordVisual acuityspa
dc.subject.keywordClinical trialspa
dc.subject.keywordFluorescence angiographyspa
dc.subject.keywordInjectionspa
dc.subject.keywordMiddle agedspa
dc.subject.keywordMulticenter studyspa
dc.subject.keywordPathologyspa
dc.subject.keywordRetina blood vesselspa
dc.subject.keywordRetina diseasespa
dc.subject.keywordRetina foveaspa
dc.subject.keywordRetrospective studyspa
dc.subject.keywordTelangiectasiaspa
dc.subject.keywordVitreous bodyspa
dc.subject.keywordAgedspa
dc.subject.keywordFemalespa
dc.subject.keywordFluorescein angiographyspa
dc.subject.keywordFovea centralisspa
dc.subject.keywordGlucocorticoidsspa
dc.subject.keywordHumansspa
dc.subject.keywordInjectionsspa
dc.subject.keywordMalespa
dc.subject.keywordMiddle agedspa
dc.subject.keywordRetinal diseasesspa
dc.subject.keywordRetinal vesselsspa
dc.subject.keywordRetrospective studiesspa
dc.subject.keywordTelangiectasisspa
dc.subject.keywordTreatment outcomespa
dc.subject.keywordTriamcinolone acetonidespa
dc.subject.keywordVisual acuityspa
dc.subject.keywordVitreous bodyspa
dc.subject.keywordJuxtafoveolar telangiectasisspa
dc.subject.keywordMacular edemaspa
dc.subject.keywordMacular telangiectasiaspa
dc.subject.keywordParafoveal telangiectasisspa
dc.subject.keywordPerifoveal telangiectasiaspa
dc.subject.keywordTriamcinolonespa
dc.titleLong-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasiaspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos